SER

Handel nachbörslich: 2.14 0.13 +6.47%

Serina Therapeutics Inc (SER)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Serina Therapeutics Inc Stock (SER) Company Profile

Serina Therapeutics Inc

Healthcare (1062)

Biotechnology (592)

(256) 327-9630

601 GENOME WAY, HUNTSVILLE

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SER's Discussions on Twitter

Compare SER vs VRTX, MRNA, REGN, ARGX, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SER Serina Therapeutics Inc	2.01	53.09M	130.00K	-21.29M	-18.29M	-1.977
VRTX Vertex Pharmaceuticals Inc	527.67	133.37B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	197.28	79.40B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	752.25	81.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	972.25	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	201.74	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-14	Eingeleitet	H.C. Wainwright	Buy

Serina Therapeutics Inc Aktie (SER) Neueste Nachrichten

Finanzdaten der Serina Therapeutics Inc-Aktie (SER)

Serina Therapeutics Inc (SER)

Serina Therapeutics Inc Stock (SER) Company Profile

Compare SER vs VRTX, MRNA, REGN, ARGX, RVMD

Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades

Serina Therapeutics Inc Aktie (SER) Neueste Nachrichten

Serina Therapeutics, Inc. (2BO.F) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Serina Therapeutics, Inc. (SER) stock price, news, quote and history - Yahoo Finance UK

Serina Therapeutics CEO Steven Ledger to Discuss SER-252 Clinical Progress at Tribe Public Webinar on Advanced Parkinson’s Disease - Quiver Quantitative

SER Should I Buy - intellectia.ai

Serina Therapeutics at H.C. Wainwright conference: Parkinson’s push advances By Investing.com - Investing.com South Africa

Serina Therapeutics at H.C. Wainwright conference: Parkinson’s push advances - Investing.com India

Serina Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times

Serina Therapeutics will present its neurological disease work Sept. 14. - Stock Titan

Serina Therapeutics Announces Independent Committee Recommends Advance of SER-252 Parkinson’s Study to Cohort 2 | SER Stock News - Quiver Quantitative

Some Parkinson’s patients showed sustained motor improvement in Serina’s study - Stock Titan

Serina Therapeutics (SER) Dips 2.40% to $2.44, Testing Key Support at $2.32Block Trade Flow - vinanet.vn

Serina Therapeutics, Inc. SEC Filing (Sep 1, 2026) - Stock Titan

Serina Therapeutics Establishes Flexible Equity Financing Agreement - The Globe and Mail

Serina Therapeutics Secures $25 Million Equity Financing Facility with Roth Principal - Minichart

Serina Therapeutics Sets Up $25 Million Equity Purchase Facility With Roth Principal Investments - TradingView

IPO Databook: Serina Therapeutics (SER US)Aug 2026 - Smartkarma

Serina TherapeuticsOffers Up To 12,500,000 Shares Of Common Stock By Roth Principal InvestmentsSEC Filing - TradingView

BTIG Maintains Serina Therapeutics(SER.US) With Buy Rating, Maintains Target Price $8 - Moomoo

Serina Therapeutics, Inc. announced that it expects to receive $25 million in funding from Roth Principal Investments, LLC - marketscreener.com

Serina (SER) Move: Ends Lower by 1.53% at $2.58 in the Latest Reading; Next Session: the Near-Term Reference Band Stretches From $2.45 to $2.71 in the Available RecordSwing Entry Signals - vinanet.vn

Serina Therapeutics Q2 loss widens to $(0.55) as revenue drops to zero - scanx.trade

Serina Therapeutics Completes Dosing for 8 Parkinson’s Patients - Stock Titan

Serina Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Serina Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates - GlobeNewswire

Serina Therapeutics Inc (SER) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

SER Q1 2026 Earnings: Wider Loss Falls Short of Estimates Despite Modest Share GainAdjusted Earnings Analysis - dars.gov.et

Serina Therapeutics Inc (SER) Stock News Today - TradingKey

Serina Therapeutics (SER) Holds Steady Above $2.24 Support, Up 0.43% in Measured SessionZigzag Correction - careplusvn.com

Serina Therapeutics (SER) Advances 5.83% to $2.18, Approaching Key Resistance at $2.29High Volume Node - dars.gov.et

SER Q1 2026 Earnings: Wider-than-Expected Loss of -$0.58 per Share Signals Rising Pipeline CostsEarnings Call Highlights - vinanet.vn

Serina Therapeutics Inc. (SER) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Continues to Invest in PipelineReturn On Equity - dars.gov.et

Serina Therapeutics Inc. (SER) Holds Steady Near $2.07 as Traders Eye Tight Trading RangeETF AUM Growth - dars.gov.et

Serina Therapeutics Inc (SER) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Serina Therapeutics Inc (SER) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Serina Therapeutics Inc (SER) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

SER|Serina Therapeutics Inc|Price:2.030|Chg%:-0.040 - TradingKey

Serina Therapeutics Market Sentiment - Benzinga España

Serina Therapeutics Inc (SER) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Serina Therapeutics Inc (SER) Balance Sheet - TradingKey

Serina Therapeutics, Inc. Revenue Breakdown – AMEX:SER - TradingView

Serina Therapeutics, Inc. Revenue Breakdown – TRADEGATE:2BO - TradingView

TradingKey - TradingKey

Serina Therapeutics Inc (SER) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

SER|Serina Therapeutics Inc|Price:1.990|Chg%:-0.080 - TradingKey

Serina Therapeutics to present at BTIG Virtual Biotechnology Conference July 28-29, 2026 - Pluang

Serina Therapeutics, Inc. Amended CEO Employment Agreement and SEC Filing Details – July 2026 - Minichart

Serina Therapeutics to Participate in the BTIG Virtual Biotechnology Conference - The Manila Times

Serina Sets July 29 Virtual Investor Meetings at BTIG Event - Stock Titan

Form 4 Serina Therapeutics Inc For: 23 July By Investing.com - Investing.com Canada

Serina Therapeutics director Simon Farrell files initial beneficial ownership statement - Bitget

Director Simon Farrell awarded 30,500 options at Serina (SER) - Stock Titan

Finanzdaten der Serina Therapeutics Inc-Aktie (SER)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SER